(NEW YORK)Shares of drug maker King Pharmaceuticals Inc. rose Thursday after a Natixis Bleichroeder analyst upgraded the stock, pointing to its "astounding" low levels.READ MORE
(ZURICH, Switzerland)Switzerland's blue-chip index SMI dropped 4.5 percent Thursday to close below 6,000 for the first time since April 2005. Declines in shares of Swiss pharmaceutical companies helped...READ MORE
(NEW YORK)Cowen and Co. analyst Sara Michelmore downgraded shares of Gen-Probe Inc. to "Neutral" from "Outperform" Friday, saying sales of the blood-screening system Ultrio not reaching prev...READ MORE
(CAMBRIDGE, Mass.)Biotechnology company Molecular Insight Pharmaceuticals Inc. on Monday added four new directors to its board, including employees of GlaxoSmithKline PLC and Novartis AG.READ MORE
(NEW YORK)Biotechnology company Amgen Inc. released widely anticipated data Tuesday showing its osteoporosis drug candidate denosumab dramatically cut the risk of spinal and hip fractures in...READ MORE
(BASEL, Switzerland)Swiss pharmaceutical company Novartis AG said Friday it would take a $235 million impairment charge in the next quarter after deciding to drop its development of a new antibiotic d...READ MORE